Press Release: ROSEN, A LEADING LAW FIRM, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – REGN
NEW YORK, Feb. 11, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) between November 2, 2023 and October 30, 2024, both dates inclusive (the “Class Period”), of the important March 10, 2025 lead plaintiff deadline.
Press Release: ROSEN, A LEADING LAW FIRM, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – REGN - Newscast
Tue, 25 Mar 2025 12:41:00 GMT New York, New York-- (Newsfile Corp. - March 25, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Elastic N.V. (NYSE: ESTC) between May 31, 2024 and ...
Mon, 24 Mar 2025 15:00:00 GMT NEW YORK, NY / ACCESS Newswire / March 24, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Dave Inc.
Sat, 22 Mar 2025 16:26:00 GMT Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has ...
Sat, 22 Mar 2025 07:26:00 GMT Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has ...
Sun, 02 Mar 2025 05:45:00 GMT On this news ... Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each ...